ST2 (sST2): A Practical Guide for Researchers

Updated 2026-09-28

What soluble ST2 is, how it signals cardiac stress via the IL-33 axis, and how research groups use recombinant sST2 in assay development and immunology.

What soluble ST2 is

ST2 (also IL1RL1) is the receptor for IL-33. In its membrane-bound form it participates in Th2-type immune signalling; in its soluble form (sST2) it acts as a decoy receptor and circulates as a biomarker of cardiac stress, fibrosis and remodelling. Elevated sST2 predicts adverse outcomes in heart failure independently of BNP and troponin.

Why laboratories buy recombinant sST2

Research groups use recombinant sST2 for IL-33 binding studies, cell-stimulation controls, and as antigen or calibrator material when building sST2 immunoassays. Because it is consumed in every experiment, reordering is frequent — which makes lot-to-lot consistency the single most important supplier property.

What to look for in a supplier

A lot-specific CoA with HPLC or SDS-PAGE purity data, a stated expression format, low endotoxin for cell-based work, and cold-chain shipping. Ask for the documentation package before you order, not after.

What the evidence base actually shows

The case for measuring sST2 rests on a chain of evidence rather than a single study, and knowing the chain matters if you have to justify the measurement to a supervisor or a reviewer. Weinberg and colleagues established in 2002 that ST2 is expressed and regulated in cardiomyocytes and is induced after myocardial infarction, which put the soluble receptor on the cardiac map in the first place. Five years later Sanada and colleagues showed that IL-33 and ST2 form a biomechanically induced, cardioprotective signalling system — giving the axis a mechanism rather than an association. Januzzi and colleagues then carried the marker into the emergency department in the PRIDE cohort, measuring ST2 in patients presenting with acute dyspnoea and finding prognostic information there. The clinical position was consolidated by the International ST2 Consensus Panel, which reviewed the biology and set out where the marker adds information. The practical reading for a laboratory is narrow but important: sST2 is not a diagnostic test for heart failure. It is a prognostic and mechanistic marker, and it is most useful alongside a natriuretic peptide rather than instead of one.

How the field has moved since the original papers

Two developments matter for a group entering this area now. First, the measurement itself matured: high-sensitivity assays widened the usable analytical range and made serial measurement practical, and a meta-analysis across chronic heart failure cohorts confirmed that the prognostic signal holds up when studies are pooled rather than read one at a time. Second, the biology broadened well beyond the heart. IL-33 is now understood as an alarmin released from barrier and structural tissues, with sST2 acting as its decoy receptor in lung, gut and adipose tissue as well as myocardium. For a laboratory that breadth is an opportunity — the same reagent serves cardiac research and immunology — but only if the specification matches the experiment. A group running cell stimulation and a group preparing a clinical calibrator both need this protein, and they should not be buying the same grade of it.

Ask a technical question